Sana Biotechnology, Inc. Common Stock (SANA) is a publicly traded Healthcare sector company. As of May 21, 2026, SANA trades at $3.10 with a market cap of $846.01M and a P/E ratio of -3.22. SANA moved +1.31% today. Year to date, SANA is -23.40%; over the trailing twelve months it is +48.80%. Its 52-week range spans $1.26 to $7.30. Analyst consensus is strong buy with an average price target of $10.17. Rallies surfaces SANA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sana Biotechnology Raises $69M via ATM Sale, Boosts Cash Runway to Mid-2027: Sana Biotechnology sold 21,607,878 common shares via its ATM facility for net proceeds of approximately $69 million. Combined with a $25 million Mayo Clinic investment, the company has secured $94 million in new capital since Q1 end, extending its cash runway to mid-2027.
| Metric | Value |
|---|---|
| Price | $3.10 |
| Market Cap | $846.01M |
| P/E Ratio | -3.22 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.30 |
| 52-Week Low | $1.26 |
| Volume | 1.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-244.17M |
| Gross Margin | 0.00% |
7 analysts cover SANA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.17.